320 related articles for article (PubMed ID: 37718249)
1. A-to-I RNA editing by ADAR and its therapeutic applications: From viral infections to cancer immunotherapy.
Datta R; Adamska JZ; Bhate A; Li JB
Wiley Interdiscip Rev RNA; 2023 Sep; ():e1817. PubMed ID: 37718249
[TBL] [Abstract][Full Text] [Related]
2. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication.
Liao GR; Tseng YY; Tseng CY; Lin FY; Yamada Y; Liu HP; Kuan CY; Hsu WL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651363
[TBL] [Abstract][Full Text] [Related]
3. The role of RNA editing enzyme ADAR1 in human disease.
Song B; Shiromoto Y; Minakuchi M; Nishikura K
Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted roles of RNA editing enzyme ADAR1 in innate immunity.
Jarmoskaite I; Li JB
RNA; 2024 Apr; 30(5):500-511. PubMed ID: 38531645
[TBL] [Abstract][Full Text] [Related]
5. ADAR1, inosine and the immune sensing system: distinguishing self from non-self.
Liddicoat BJ; Chalk AM; Walkley CR
Wiley Interdiscip Rev RNA; 2016; 7(2):157-72. PubMed ID: 26692549
[TBL] [Abstract][Full Text] [Related]
6. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR
Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108
[TBL] [Abstract][Full Text] [Related]
7. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
Sinigaglia K; Wiatrek D; Khan A; Michalik D; Sambrani N; Sedmík J; Vukić D; O'Connell MA; Keegan LP
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):356-369. PubMed ID: 30391332
[TBL] [Abstract][Full Text] [Related]
8. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
9. In search of critical dsRNA targets of ADAR1.
Levanon EY; Cohen-Fultheim R; Eisenberg E
Trends Genet; 2024 Mar; 40(3):250-259. PubMed ID: 38160061
[TBL] [Abstract][Full Text] [Related]
10. Malignant A-to-I RNA editing by ADAR1 drives T-cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing.
Rivera M; Zhang H; Pham J; Isquith J; Zhou QJ; Sasik R; Mark A; Ma W; Holm F; Fisch KM; Kuo DJ; Jamieson C; Jiang Q
Res Sq; 2023 Jun; ():. PubMed ID: 37398458
[TBL] [Abstract][Full Text] [Related]
11. ADAR1p150 prevents MDA5 and PKR activation via distinct mechanisms to avert fatal autoinflammation.
Hu SB; Heraud-Farlow J; Sun T; Liang Z; Goradia A; Taylor S; Walkley CR; Li JB
Mol Cell; 2023 Nov; 83(21):3869-3884.e7. PubMed ID: 37797622
[TBL] [Abstract][Full Text] [Related]
12. Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.
Samuel CE
J Biol Chem; 2019 Feb; 294(5):1710-1720. PubMed ID: 30710018
[TBL] [Abstract][Full Text] [Related]
13. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
[TBL] [Abstract][Full Text] [Related]
14. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.
Heraud-Farlow JE; Chalk AM; Linder SE; Li Q; Taylor S; White JM; Pang L; Liddicoat BJ; Gupte A; Li JB; Walkley CR
Genome Biol; 2017 Sep; 18(1):166. PubMed ID: 28874170
[TBL] [Abstract][Full Text] [Related]
15. ADAR regulates APOL1 via A-to-I RNA editing by inhibition of MDA5 activation in a paradoxical biological circuit.
Riella CV; McNulty M; Ribas GT; Tattersfield CF; Perez-Gill C; Eichinger F; Kelly J; Chun J; Subramanian B; Guizelini D; ; Alper SL; Pollak MR; Sampson MG; Friedman DJ
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2210150119. PubMed ID: 36282916
[No Abstract] [Full Text] [Related]
16. ADAR1-mediated RNA editing is required for thymic self-tolerance and inhibition of autoimmunity.
Nakahama T; Kato Y; Kim JI; Vongpipatana T; Suzuki Y; Walkley CR; Kawahara Y
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30361393
[TBL] [Abstract][Full Text] [Related]
17. Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing.
Rivera M; Zhang H; Pham J; Isquith J; Zhou QJ; Balaian L; Sasik R; Enlund S; Mark A; Ma W; Holm F; Fisch KM; Kuo DJ; Jamieson C; Jiang Q
Cell Rep; 2024 Feb; 43(2):113704. PubMed ID: 38265938
[TBL] [Abstract][Full Text] [Related]
18. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
[TBL] [Abstract][Full Text] [Related]
19. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
20. RNA editing underlies genetic risk of common inflammatory diseases.
Li Q; Gloudemans MJ; Geisinger JM; Fan B; Aguet F; Sun T; Ramaswami G; Li YI; Ma JB; Pritchard JK; Montgomery SB; Li JB
Nature; 2022 Aug; 608(7923):569-577. PubMed ID: 35922514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
